The effect of recombinant erythropoietin on long-term outcome after moderate-to-severe traumatic brain injury

PURPOSE: Recombinant erythropoietin (EPO) administered for traumatic brain injury (TBI) may increase short-term survival, but the long-term effect is unknown. METHODS: We conducted a pre-planned long-term follow-up of patients in the multicentre erythropoietin in TBI trial (2010–2015). We invited su...

Descripción completa

Detalles Bibliográficos
Autores principales: Skrifvars, Markus B., Luethi, Nora, Bailey, Michael, French, Craig, Nichol, Alistair, Trapani, Tony, McArthur, Colin, Arabi, Yaseen M., Bendel, Stepani, Cooper, David J., Bellomo, Rinaldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353955/
https://www.ncbi.nlm.nih.gov/pubmed/37405413
http://dx.doi.org/10.1007/s00134-023-07141-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353955/
https://www.ncbi.nlm.nih.gov/pubmed/37405413
http://dx.doi.org/10.1007/s00134-023-07141-5

Ejemplares similares